SEC Form 4/A · accession 0001615219-16-000143
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Christoph H Westphal
Officer — President and CEO · Director · 10% Owner
Period of report
Mar 22, 2016
Accepted (ET)
Mar 25, 2016 · 2:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2016 | P | 23,951 | $11.78 | A | 2,910,955 | I | See notes |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The Form 4 filed on March 23, 2016 reported the purchase of 23,951 shares on March 21, 2016. This Amendment is being filed to correct the date of purchase. The rest of the information disclosed in the original filing for this purchase, including the footnotes, remains the same.